Airsculpt Technologies, Inc. Stock Price, News & Analysis

AirSculpt Technologies (NASDAQ: AIRS) has announced the opening of its new body contouring center in White Plains, NY, marking its 32nd location. The new facility features three operating rooms for simultaneous procedures and offers the AirSculpt+ skin tightening procedure. This expansion represents the company's second location in New York, responding to growing market demand. The AirSculpt+ procedure combines fat removal with Renuvion® technology, using helium gas and radiofrequency energy for skin tightening. Since 2012, over 60,000 AirSculpt procedures have been performed across their locations in the U.S., Canada, and the United Kingdom.

AirSculpt Technologies (NASDAQ:AIRS) reported Q3 2024 results with revenue of $42.5 million, representing a 9.1% decline from Q3 2023. The company posted a net loss of $6.0 million and Adjusted EBITDA of $4.7 million. Case volume decreased 4.3% to 3,277 cases. Despite challenges in the consumer environment, the company opened four new centers during the quarter. For the first nine months of 2024, revenue declined 4.8% to $141.2 million. The company affirmed its 2024 guidance with revenue expected between $183-189 million and Adjusted EBITDA between $23-28 million.

AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leader in premium body contouring procedures, has opened a new center in Birmingham, MI, increasing its total locations to 31. The center, located at 555 S. Old Woodward Avenue Suite 500, features two operating rooms for concurrent procedures and offers the popular AirSculpt®+ skin tightening procedure.

Dennis Dean, Interim CEO, expressed excitement about introducing AirSculpt's exclusive technology to Birmingham. The clinic is situated on the main strip, surrounded by upscale retail shops. AirSculpt®+ combines AirSculpt® fat removal with Renuvion® treatment, using helium gas and radiofrequency energy to tighten skin and improve laxity.

Since 2012, over 60,000 AirSculpt® cases have been performed across the company's locations in the U.S., Canada, and the United Kingdom.

AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leading provider of premium body contouring procedures, has announced the opening of a new center in Deerfield, IL. This expansion brings the company's total location count to 30. The new center, located at 720 Waukegan Rd Suite 200, features three operating rooms and offers the popular AirSculpt®+ skin tightening procedure.

Dennis Dean, Interim CEO, expressed excitement about bringing AirSculpt's proprietary technology to Deerfield, citing strong demand in their existing Chicago clinic. The AirSculpt®+ procedure combines AirSculpt® fat removal with Renuvion® skin tightening technology, offering patients a comprehensive body contouring solution.

Since 2012, AirSculpt® has performed over 60,000 cases across its locations in the U.S., Canada, and the United Kingdom. The company continues to expand its presence to meet growing market demand for premium body contouring services.

AirSculpt® Technologies, Inc. (NASDAQ: AIRS), a leader in premium body contouring, has opened its 29th center in Columbus, OH. The new facility, located at 4100 Regent St Suite 4-H in Easton Town Center, features two operating rooms for concurrent procedures. The center also offers the popular AirSculpt®+ skin tightening procedure, which combines AirSculpt® fat removal with Renuvion® technology for improved skin laxity. This minimally invasive treatment uses helium gas and radiofrequency energy to create a plasma that corrects sagging skin and restores a youthful appearance. Since 2012, AirSculpt® has performed over 60,000 cases across its locations in the U.S., Canada, and the United Kingdom.

AirSculpt Technologies (NASDAQ:AIRS) reported Q2 2024 results with revenue of $51.0 million, a net loss of $3.2 million, and Adjusted EBITDA of $6.9 million. The company faced challenges due to a difficult consumer spending environment and increased brand awareness spend. Key points include:

- Case volume declined 5.7% to 3,949
- Revenue decreased 8.4% year-over-year
- Net loss of $3.2 million compared to $1.8 million net income in Q2 2023
- Adjusted EBITDA of $6.9 million, down from $14.6 million in Q2 2023

AirSculpt revised its 2024 guidance, projecting revenues of $180-$190 million and Adjusted EBITDA of $23-$28 million. The company plans to open five new centers in H2 2024. Dennis Dean has been appointed Interim CEO following Todd Magazine's resignation.

AirSculpt Technologies, Inc. (NASDAQ:AIRS), a national provider of premium body contouring procedures, has announced significant leadership changes. Todd Magazine has stepped down as Chief Executive Officer and Board member, transitioning to an advisory role until December 31, 2024. Dennis Dean, the company's Chief Financial Officer, has been appointed as interim CEO while a search for a permanent successor is conducted.

Dr. Aaron Rollins, Executive Chairman, expressed confidence in the company's business model and growth potential. The focus will be on core body contouring procedures, reducing long-term marketing spend, and increasing fiscal discipline in response to the current economic environment. Dennis Dean emphasized the company's plan to focus on core operations, reduce expenses, and position for efficient scaling to deliver consistent revenue growth with industry-leading EBITDA margins as conditions improve.

AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures, has announced its plans to report second quarter 2024 financial results. The company will release its earnings before the market opens on Friday, August 9, 2024, followed by a conference call at 8:30 a.m. Eastern Time on the same day.

Investors and interested parties can access the conference call by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871. Alternatively, they can request a return call for instant telephone access. A live webcast of the call will be available on the investor relations section of the AirSculpt Technologies website, with a replay accessible for approximately 90 days after the event.

AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a 2.9% increase in first-quarter cases to 3,746 and a 3.9% revenue increase to $47.6 million. Net income rose to $6.0 million from a loss in the previous year. The company plans six new center openings in 2024 and maintains revenue guidance of $220 million.